The Artemis II crew is scheduled to splash down in the Pacific Ocean on Friday evening, ending a roughly 10-day flight that NASA packed with studies spanning nearly every major system in the body. Commander Reid Wiseman and his crewmates wore sensors that continuously tracked hydration, breathing, cardiovascular performance and radiation exposure while the mission flew around the moon.
NASA also used portable ultrasound machines so crew members could evaluate cardiovascular function and internal organs without a physician physically present. An immune biomarkers investigation tracked how deep space conditions affected stress hormones, immune cells and dormant viruses through blood and saliva samples, while astronauts blotted saliva onto special paper booklets because refrigeration was not an option in Orion’s tight quarters. Wrist-worn devices monitored sleep, activity and behavioral performance in real time.
The mission reflects how far space medicine has moved since the lunar flights of the 1960s, when doctors mainly followed heart rate telemetry and limited metabolic data. On long-duration missions to the International Space Station, bones have been shown to weaken at rates of about 1% to 1.5% per month, muscles shrink without daily exercise, and the cardiovascular system adapts to microgravity with lower blood plasma volume and changes in heart function.
Read Also: Apollo 11 echoes as NASA stands behind Artemis 2 heat shield
That is why the Artemis II data matter beyond one trip. NASA is treating the mission as a rehearsal for days, and eventually months, away from Earth, including future travel to Mars. A recent MS NOW article framed the point plainly: if Artemis II is to help make sustained human exploration possible, then one of its contributions must be helping scientists figure out how to keep astronauts safe far from home.
Read Also: Artemis Photos show Earthset, eclipse and moon’s far side in rare flyby
The work is especially important because some effects of weightlessness are still not fully understood. Astronauts can develop spaceflight-associated neuro-ocular syndrome in microgravity, a condition tied to swelling of the optic nerve and subtle changes in vision caused by fluid shifting toward the head. Most symptoms improved after astronauts returned to Earth, but it remains an active research concern for longer missions. NASA’s challenge now is turning the flood of Artemis II measurements into rules that can protect crews before they leave Earth’s reach.
